Let's say an idealistic grad student constructs a novel recombinant DNA vector - e.g. plasmid or virus - and publishes the method under a Creative Commons attribution-non-commercial-share-alike license on a personal website or blog without his or her advisor's knowledge. (Which would be a really stupid thing to do, but that's beside the point for now.) Then the advisor, who's also part of a biotech company, submits a patent for the vector with the intention of producing and selling it commercially. Which would apply, the CC license or the patent?
Tags: